Biondo Investment Advisors, LLC Bluebird Bio, Inc. Transaction History

Biondo Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 05, 2019	SELL	$59.47 - $93.1 $100,801 - $157,804	-1,695 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$64.44 - $104.11 $109,225 - $176,466	1,695 New	1,695 $267,000
Q4 2018 Feb 08, 2019	SELL	$59.1 - $93.26 $100,174 - $158,075	-1,695 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$88.86 - $117.49 $4,443 - $5,874	50 Added 3.04%	1,695 $247,000
Q2 2018 Aug 02, 2018	BUY	$99.64 - $127.59 $3,487 - $4,465	35 Added 2.17%	1,645 $258,000
Q1 2018 May 02, 2018	BUY	$105.8 - $150.94 $26,450 - $37,735	250 Added 18.38%	1,610 $275,000
Q4 2017 Feb 07, 2018	SELL	$81.25 - $130.7 $9,750 - $15,683	-120 Reduced 8.11%	1,360 $242,000
Q3 2017 Nov 08, 2017	BUY	$57.74 - $91.42 $85,455 - $135,301	1,480	1,480 $203,000

150

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $606M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Biondo Investment Advisors, LLC with notifications on news.